Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Blocking IL-8 can reduce skin rashes from cancer treatment.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Certain medications can cause serious side effects, so it's important to report them.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Finasteride slows down motherly behavior in first-time pregnant rats.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Consider DRIF and perform skin biopsies for persistent papular rashes.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.